SCHEMBL910460

SCHEMBL910460

NCCCCCC(N)C(=O)OCc1ccccc1[N+](=O)[O-]

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.41
ALDH1A1 P00352 3/20 0.40
HTT P42858 1/20 0.40
DPP8 Q6V1X1 1/20 0.40
DPP9 Q86TI2 1/20 0.40
DPP7 Q9UHL4 1/20 0.40
MMP2 P08253 1/20 0.39
POLB P06746 1/20 0.39
CYP2C19 P33261 1/20 0.39
KAT2B Q92831 2/20 0.39
TSHR P16473 1/20 0.39
LTA4H P09960 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
KDM4A O75164 1/20 0.38
MC4R P32245 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29175065 0.99 MAOB (0.43) MAOBL3MBTL1ALDH1A1HTTDPP8
SCHEMBL3612596 0.89 L3MBTL1 (0.46) MAOBL3MBTL1ALDH1A1HTTPOLB
SCHEMBL1053905 0.88 MAOB (0.45) MAOBL3MBTL1ALDH1A1HTTPOLB
SCHEMBL3386491 0.86 MMP2 (0.40) L3MBTL1ALDH1A1DPP8DPP9DPP7
SCHEMBL23525317 0.82 ALDH1A1 (0.49) MAOBL3MBTL1ALDH1A1HTTPOLB
SCHEMBL3612598 0.81 MAOB (0.45) MAOBL3MBTL1ALDH1A1HTTKAT2B
SCHEMBL1053907 0.81 MAOB (0.45) MAOBL3MBTL1ALDH1A1HTTKAT2B
SCHEMBL8079883 0.81 MAOB (0.45) MAOBL3MBTL1ALDH1A1HTTKAT2B
SCHEMBL7897984 0.81 MAOB (0.47) MAOBL3MBTL1ALDH1A1HTTPOLB
SCHEMBL1057910 0.81 KMT2A (0.51) MAOBL3MBTL1ALDH1A1HTTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020022410-A1 COMPOSITION FOR FORMING PROTECTIVE FILM FOR TRANSPARENT CONDUCTIVE FILM 日産化学株式会社 2020-01-30 WO disclosed
US-9441065-B2 Curable composition for imprints, cured product and method for manufacturing a cured product FUJIFILM CORPORATION (JP) 2016-09-13 US disclosed
US-8282872-B2 (Meth)acrylate compound, curable composition using the same, curable composition for photo-nanoimprints, cured product of curable composition and method for manufacturing cured product FUJIFILM CORPORATION (JP) 2012-10-09 US disclosed
US-20110003909-A1 (METH)ACRYLATE COMPOUND, CURABLE COMPOSITION USING THE SAME, CURABLE COMPOSITION FOR PHOTO-NANOIMPRINTS, CURED PRODUCT OF CURABLE COMPOSITION AND METHOD FOR MANUFACTURING CURED PRODUCT FUJIFILM CORPORATION 2011-01-06 US disclosed
US-6180320-B1 Method of manufacturing a semiconductor device having a fine pattern, and semiconductor device manufactured thereby MITSUBISHI DENKI KABUSHIKI KAISHA (JP) 2001-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003909-A1 (METH)ACRYLATE COMPOUND, CURABLE COMPOSITION USING THE SAME, CURABLE COMPOSITION FOR PHOTO-NANOIMPRINTS, CURED PRODUCT OF CURABLE COMPOSITION AND METHOD FOR MANUFACTURING CURED PRODUCT DNMT3A, DOT1L, PDE6D MAOB 1378/4885L3MBTL1 1079/4885ALDH1A1 195/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.